Understanding ALS requires seeing both the whole landscape and the individual within it.
IDM integrates diverse data and applies advanced analytics to reveal patterns that can transform research and therapeutic development.
How IDM Works
Secure responsible data access
Harmonize and quality-check information
Define clinical trajectories and subgroups
Analyze biological and treatment-related signals
Review findings with clinical and scientific experts
Data Harmonization
Datasets collected by different organizations, using different protocols and formats, cannot always be directly compared. IDM connects them into a shared research framework that enables cross-dataset analysis.
Outlier Discovery
Unusual patients can sometimes expose protective biology, treatment-response signals, measurement issues, or new research hypotheses.
Biological & Biomarker Insight
IDM integrates genomic, biomarker, digital, and patient-reported data to uncover meaningful biological signals.
Progression Intelligence
IDM characterizes distinct progression phenotypes and trajectories to better understand heterogeneity in ALS.
Clinical-Trial Intelligence
IDM applies insights to patient identification, biomarker strategy, trial design, and retrospective analysis.
IDM's analyses are intended for research and therapeutic-development purposes. Research-grade findings may require independent replication and appropriate clinical validation.